First line drug for falciparum malaria in pregnancy is :
**Core Concept**
Malaria during pregnancy poses a significant risk to both the mother and the fetus. Falciparum malaria, caused by Plasmodium falciparum, requires prompt and effective treatment to prevent severe complications. The choice of antimalarial drug in pregnancy is critical, considering the potential risks to the fetus.
**Why the Correct Answer is Right**
The first-line treatment for falciparum malaria in pregnancy is Artemisinin-based Combination Therapy (ACT). Artemisinin acts by generating free radicals that damage the parasite's membrane, ultimately leading to its death. In pregnancy, the recommended ACT is Artesunate plus Amodiaquine. This combination is chosen for its efficacy and safety profile in preventing recurrence and treating the infection.
**Why Each Wrong Option is Incorrect**
**Option A:** Chloroquine is generally contraindicated in areas with chloroquine-resistant P. falciparum and is not recommended as a first-line treatment in pregnancy due to concerns of resistance and potential adverse effects.
**Option B:** Quinine is an alternative treatment for falciparum malaria but is not typically used as a first-line option in pregnancy due to its potential side effects, such as hypoglycemia and thrombocytopenia.
**Option C:** Sulfadoxine-Pyrimethamine (SP) is often used in combination with other antimalarials for intermittent preventive treatment of malaria in pregnancy. However, it is not the first-line treatment for falciparum malaria due to concerns of resistance.
**Clinical Pearl / High-Yield Fact**
It's crucial to note that the choice of antimalarial drug in pregnancy should be guided by the local resistance pattern and the gestational age of the patient. In areas with high resistance, alternative regimens like Quinine plus Clindamycin or Artesunate plus Mefloquine may be considered.
**Correct Answer:** A. Artesunate plus Amodiaquine.